BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 7479420)

  • 1. Deep vein thrombosis prophylaxis in the outpatient setting: preventing complications following hospital discharge.
    Turpie AG
    Orthopedics; 1995 Jul; 18 Suppl():15-7. PubMed ID: 7479420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep vein thrombosis prophylaxis in the outpatient setting: preventing complications following hospital discharge.
    Turpie AG
    Orthopedics; 1995 Jul; 18():15-7. PubMed ID: 24826736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing DVT following total knee replacement: a review of recent clinical trials.
    Fitzgerald RH
    Orthopedics; 1995 Jul; 18 Suppl():10-1. PubMed ID: 7479418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C; Mouret P
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, natural history and risk factors of deep vein thrombosis in elective knee arthroscopy.
    Delis KT; Hunt N; Strachan RK; Nicolaides AN
    Thromb Haemost; 2001 Sep; 86(3):817-21. PubMed ID: 11583313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of venous thromboembolism in high-risk surgical and medical patients.
    Prandoni P; Sabbion P; Tanduo C; Errigo G; Zanon E; Bernardi E
    Semin Vasc Med; 2001; 1(1):61-70. PubMed ID: 15199515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low molecular weight heparin for the prevention of deep vein thrombosis following orthopedic surgery.
    Lassen MR; Borris LC
    Curr Opin Pulm Med; 1996 Jul; 2(4):300-4. PubMed ID: 9363156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective.
    Hull RD; Raskob GE; Pineo GF; Feldstein W; Rosenbloom D; Gafni A; Green D; Feinglass J; Trowbridge AA; Elliott CG
    Arch Intern Med; 1997 Feb; 157(3):298-303. PubMed ID: 9040296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of venous thromboembolism.
    Stringer MD; Kakkar VV
    Herz; 1989 Jun; 14(3):135-47. PubMed ID: 2661385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.
    Bell GK; Goldhaber SZ
    Vasc Med; 2001; 6(1):23-9. PubMed ID: 11358156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishing a universal protocol for deep vein thrombosis following orthopedic surgery: total knee arthroplasty.
    Sculco TP
    Orthopedics; 1996 Aug; 19 Suppl():6-8. PubMed ID: 8856784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis.
    Sarasin FP; Bounameaux H
    Thromb Haemost; 2002 Apr; 87(4):586-92. PubMed ID: 12008939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep vein thrombosis: prophylaxis, diagnosis, and treatment--lessons from orthopedic studies.
    Paiement GD; Desautels C
    Clin Cardiol; 1990 Apr; 13(4 Suppl 6):VI19-22. PubMed ID: 2191811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consortium data: comparative efficacy of low molecular weight heparin and warfarin following total hip replacement.
    Colwell CW
    Orthopedics; 1995 Jul; 18 Suppl():21-3. PubMed ID: 7479422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent pneumatic compression versus coumadin. Prevention of deep vein thrombosis in lower-extremity total joint arthroplasty.
    Kaempffe FA; Lifeso RM; Meinking C
    Clin Orthop Relat Res; 1991 Aug; (269):89-97. PubMed ID: 1864061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low molecular weight heparin for the prevention and treatment of venous thromboembolism.
    Raskob GE
    Curr Opin Pulm Med; 1996 Jul; 2(4):305-10. PubMed ID: 9363157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The rationale for long-term prophylaxis of venous thromboembolism.
    Agnelli G; Mancini GB; Biagini D
    Orthopedics; 2000 Jun; 23(6 Suppl):s643-6. PubMed ID: 10875429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Warfarin vs enoxaparin for deep venous thrombosis prophylaxis after total hip & total knee arthroplasty: a cost comparison.
    Garcia-Zozaya I
    J Ky Med Assoc; 1998 Apr; 96(4):143-8. PubMed ID: 9577110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-operative plasma levels of thrombin-antithrombin III complexes correlate with the development of venous thrombosis after major hip or knee surgery.
    Ginsberg JS; Brill-Edwards P; Panju A; Patel A; McGinnis J; Smith F; Dale I; Johnston M; Ofosu F
    Thromb Haemost; 1995 Aug; 74(2):602-5. PubMed ID: 8584991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.